| Year |
Citation |
Score |
| 2019 |
Ammanamanchi S, Tillekeratne MPM, Ko TC, Brattain MG. Retraction: Endogenous Control of Cell Cycle Progression by Autocrine Transforming Growth Factor β in Breast Cancer Cells. Cancer Research. 79: 1016. PMID 34465568 DOI: 10.1158/0008-5472.CAN-19-0071 |
0.331 |
|
| 2018 |
Leiphrakpam PD, Brattain MG, Black JD, Wang JJ. TGFβ and IGF1R signaling activate protein kinase A through differential regulation of ezrin phosphorylation in colon cancer cells. The Journal of Biological Chemistry. PMID 29599290 DOI: 10.1074/jbc.RA117.001299 |
0.314 |
|
| 2018 |
Robb CM, Kour S, Contreras JI, Agarwal E, Barger CJ, Rana S, Sonawane Y, Neilsen BK, Taylor M, Kizhake S, Thakare RN, Chowdhury S, Wang J, Black JD, Hollingsworth MA, ... Brattain MG, et al. Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy. Oncotarget. 9: 5216-5232. PMID 29435174 DOI: 10.18632/Oncotarget.23749 |
0.33 |
|
| 2017 |
Bailey KL, Agarwal E, Chowdhury S, Luo J, Brattain MG, Black JD, Wang J. TGFβ/Smad3 regulates proliferation and apoptosis through IRS-1 inhibition in colon cancer cells. Plos One. 12: e0176096. PMID 28414818 DOI: 10.1371/journal.pone.0176096 |
0.354 |
|
| 2017 |
Agarwal E, Robb CM, Smith LM, Brattain MG, Wang J, Black JD, Chowdhury S. Role of Akt2 in regulation of metastasis suppressor 1 expression and colorectal cancer metastasis. Oncogene. PMID 28068324 DOI: 10.1038/Onc.2016.460 |
0.31 |
|
| 2015 |
Fisher KW, Das B, Kim HS, Clymer BK, Gehring D, Smith D, Costanzo-Garvey D, Fernandez M, Brattain MG, Kelly D, MacMillan J, White MA, Lewis RE. AMPK promotes aberrant PGC1β expression to support human colon tumor cell survival. Molecular and Cellular Biology. PMID 26351140 DOI: 10.1128/Mcb.00528-15 |
0.315 |
|
| 2014 |
Agarwal E, Chaudhuri A, Leiphrakpam PD, Haferbier KL, Brattain MG, Chowdhury S. Akt inhibitor MK-2206 promotes anti-tumor activity and cell death by modulation of AIF and Ezrin in colorectal cancer. Bmc Cancer. 14: 145. PMID 24581231 DOI: 10.1186/1471-2407-14-145 |
0.328 |
|
| 2014 |
Leiphrakpam PD, Agarwal E, Mathiesen M, Haferbier KL, Brattain MG, Chowdhury S. In vivo analysis of insulin-like growth factor type 1 receptor humanized monoclonal antibody MK-0646 and small molecule kinase inhibitor OSI-906 in colorectal cancer. Oncology Reports. 31: 87-94. PMID 24173770 DOI: 10.3892/or.2013.2819 |
0.34 |
|
| 2013 |
Hedrick ED, Agarwal E, Leiphrakpam PD, Haferbier KL, Brattain MG, Chowdhury S. Differential PKA activation and AKAP association determines cell fate in cancer cells. Journal of Molecular Signaling. 8: 10. PMID 24083380 DOI: 10.1186/1750-2187-8-10 |
0.314 |
|
| 2013 |
Zou Y, Howell GM, Humphrey LE, Wang J, Brattain MG. Ron knockdown and Ron monoclonal antibody IMC-RON8 sensitize pancreatic cancer to histone deacetylase inhibitors (HDACi). Plos One. 8: e69992. PMID 23922886 DOI: 10.1371/Journal.Pone.0069992 |
0.441 |
|
| 2013 |
Murari C, Howell GM, Brattain MG. Abstract B60: Identification of the specific histone deacetylases involved in the silencing of transforming growth factor β receptor II in colon cancer Cancer Research. 73. DOI: 10.1158/1538-7445.Cec13-B60 |
0.402 |
|
| 2012 |
Sabbah DA, Simms NA, Wang W, Dong Y, Ezell EL, Brattain MG, Vennerstrom JL, Zhong HA. N-Phenyl-4-hydroxy-2-quinolone-3-carboxamides as selective inhibitors of mutant H1047R phosphoinositide-3-kinase (PI3Kα). Bioorganic & Medicinal Chemistry. 20: 7175-83. PMID 23121722 DOI: 10.1016/J.Bmc.2012.09.059 |
0.546 |
|
| 2012 |
Simms NA, Rajput A, Sharratt EA, Ongchin M, Teggart CA, Wang J, Brattain MG. Transforming growth factor-β suppresses metastasis in a subset of human colon carcinoma cells. Bmc Cancer. 12: 221. PMID 22672900 DOI: 10.1186/1471-2407-12-221 |
0.59 |
|
| 2012 |
Sabbah DA, Simms NA, Brattain MG, Vennerstrom JL, Zhong H. Biological evaluation and docking studies of recently identified inhibitors of phosphoinositide-3-kinases. Bioorganic & Medicinal Chemistry Letters. 22: 876-80. PMID 22212721 DOI: 10.1016/J.Bmcl.2011.12.044 |
0.572 |
|
| 2011 |
Chowdhury S, Howell GM, Teggart CA, Chowdhury A, Person JJ, Bowers DM, Brattain MG. Histone deacetylase inhibitor belinostat represses survivin expression through reactivation of transforming growth factor beta (TGFbeta) receptor II leading to cancer cell death. The Journal of Biological Chemistry. 286: 30937-48. PMID 21757750 DOI: 10.1074/Jbc.M110.212035 |
0.462 |
|
| 2010 |
Are C, Simms N, Rajput A, Rajupt A, Brattain M. The role of transforming growth factor-beta in suppression of hepatic metastasis from colon cancer. Hpb : the Official Journal of the International Hepato Pancreato Biliary Association. 12: 498-506. PMID 20815859 DOI: 10.1111/J.1477-2574.2010.00219.X |
0.559 |
|
| 2010 |
Wang W, Brattain MG. Abstract 3296: Cell survival in colon cancer metastatic progression Cancer Research. 70: 3296-3296. DOI: 10.1158/1538-7445.Am10-3296 |
0.429 |
|
| 2009 |
Ongchin M, Sharratt E, Dominguez I, Simms N, Wang J, Cheney R, LeVea C, Brattain M, Rajput A. The effects of epidermal growth factor receptor activation and attenuation of the TGFbeta pathway in an orthotopic model of colon cancer. The Journal of Surgical Research. 156: 250-6. PMID 19524264 DOI: 10.1016/j.jss.2009.02.002 |
0.598 |
|
| 2009 |
Wang J, Rajput A, Kan JL, Rose R, Liu XQ, Kuropatwinski K, Hauser J, Beko A, Dominquez I, Sharratt EA, Brattain L, Levea C, Sun FL, Keane DM, Gibson NW, ... Brattain MG, et al. Knockdown of Ron kinase inhibits mutant phosphatidylinositol 3-kinase and reduces metastasis in human colon carcinoma. The Journal of Biological Chemistry. 284: 10912-22. PMID 19224914 DOI: 10.1074/Jbc.M809551200 |
0.493 |
|
| 2009 |
Sawhney RS, Liu W, Brattain MG. A novel role of ERK5 in integrin-mediated cell adhesion and motility in cancer cells via Fak signaling. Journal of Cellular Physiology. 219: 152-61. PMID 19089993 DOI: 10.1002/jcp.21662 |
0.352 |
|
| 2008 |
Hu YP, Patil SB, Panasiewicz M, Li W, Hauser J, Humphrey LE, Brattain MG. Heterogeneity of receptor function in colon carcinoma cells determined by cross-talk between type I insulin-like growth factor receptor and epidermal growth factor receptor. Cancer Research. 68: 8004-13. PMID 18829558 DOI: 10.1158/0008-5472.Can-08-0280 |
0.466 |
|
| 2008 |
Wang J, Yang L, Yang J, Kuropatwinski K, Wang W, Liu XQ, Hauser J, Brattain MG. Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells. Cancer Research. 68: 3152-60. PMID 18451140 DOI: 10.1158/0008-5472.Can-07-5348 |
0.508 |
|
| 2008 |
Zhao S, Ammanamanchi S, Brattain M, Cao L, Thangasamy A, Wang J, Freeman JW. Smad4-dependent TGF-beta signaling suppresses RON receptor tyrosine kinase-dependent motility and invasion of pancreatic cancer cells. The Journal of Biological Chemistry. 283: 11293-301. PMID 18310076 DOI: 10.1074/jbc.M800154200 |
0.316 |
|
| 2008 |
Spengler ML, Guo LW, Brattain MG. Phosphorylation mediates Sp1 coupled activities of proteolytic processing, desumoylation and degradation. Cell Cycle (Georgetown, Tex.). 7: 623-30. PMID 18239466 DOI: 10.4161/Cc.7.5.5402 |
0.581 |
|
| 2008 |
Rajput A, Dominguez San Martin I, Rose R, Beko A, Levea C, Sharratt E, Mazurchuk R, Hoffman RM, Brattain MG, Wang J. Characterization of HCT116 human colon cancer cells in an orthotopic model. The Journal of Surgical Research. 147: 276-81. PMID 17961596 DOI: 10.1016/J.Jss.2007.04.021 |
0.355 |
|
| 2007 |
Wang R, Brattain MG. The maximal size of protein to diffuse through the nuclear pore is larger than 60kDa. Febs Letters. 581: 3164-70. PMID 17588566 DOI: 10.1016/J.Febslet.2007.05.082 |
0.479 |
|
| 2007 |
Guo XN, Rajput A, Rose R, Hauser J, Beko A, Kuropatwinski K, LeVea C, Hoffman RM, Brattain MG, Wang J. Mutant PIK3CA-bearing colon cancer cells display increased metastasis in an orthotopic model. Cancer Research. 67: 5851-8. PMID 17575153 DOI: 10.1158/0008-5472.Can-07-0049 |
0.471 |
|
| 2007 |
Wang J, Kuropatwinski K, Hauser J, Rossi MR, Zhou Y, Conway A, Kan JL, Gibson NW, Willson JK, Cowell JK, Brattain MG. Colon carcinoma cells harboring PIK3CA mutations display resistance to growth factor deprivation induced apoptosis. Molecular Cancer Therapeutics. 6: 1143-50. PMID 17363507 DOI: 10.1158/1535-7163.Mct-06-0555 |
0.602 |
|
| 2007 |
Fakih MG, Trump DL, Muindi JR, Black JD, Bernardi RJ, Creaven PJ, Schwartz J, Brattain MG, Hutson A, French R, Johnson CS. A phase I pharmacokinetic and pharmacodynamic study of intravenous calcitriol in combination with oral gefitinib in patients with advanced solid tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 1216-23. PMID 17317832 DOI: 10.1158/1078-0432.Ccr-06-1165 |
0.309 |
|
| 2007 |
Rajput A, Koterba AP, Kreisberg JI, Foster JM, Willson JK, Brattain MG. A novel mechanism of resistance to epidermal growth factor receptor antagonism in vivo. Cancer Research. 67: 665-73. PMID 17234777 DOI: 10.1158/0008-5472.Can-06-2773 |
0.474 |
|
| 2006 |
Javle MM, Yu J, Khoury T, Chadha KS, Chadha KC, Iyer RV, Foster J, Kuvshinoff BW, Gibbs JF, Geradts J, Black JD, Brattain MG. Akt expression may predict favorable prognosis in cholangiocarcinoma. Journal of Gastroenterology and Hepatology. 21: 1744-51. PMID 16984600 DOI: 10.1111/J.1440-1746.2006.04373.X |
0.377 |
|
| 2006 |
Li F, Brattain MG. Role of the Survivin gene in pathophysiology. The American Journal of Pathology. 169: 1-11. PMID 16816356 DOI: 10.2353/Ajpath.2006.060121 |
0.355 |
|
| 2006 |
Chadha KS, Khoury T, Yu J, Black JD, Gibbs JF, Kuvshinoff BW, Tan D, Brattain MG, Javle MM. Activated Akt and Erk expression and survival after surgery in pancreatic carcinoma. Annals of Surgical Oncology. 13: 933-9. PMID 16788754 DOI: 10.1245/Aso.2006.07.011 |
0.361 |
|
| 2006 |
Wang R, Brattain MG. AKT can be activated in the nucleus. Cellular Signalling. 18: 1722-31. PMID 16616456 DOI: 10.1016/J.Cellsig.2006.01.020 |
0.589 |
|
| 2006 |
Sawhney RS, Cookson MM, Omar Y, Hauser J, Brattain MG. Integrin alpha2-mediated ERK and calpain activation play a critical role in cell adhesion and motility via focal adhesion kinase signaling: identification of a novel signaling pathway. The Journal of Biological Chemistry. 281: 8497-510. PMID 16461767 DOI: 10.1074/Jbc.M600787200 |
0.437 |
|
| 2006 |
Zhou Y, Li S, Hu YP, Wang J, Hauser J, Conway AN, Vinci MA, Humphrey L, Zborowska E, Willson JK, Brattain MG. Blockade of EGFR and ErbB2 by the novel dual EGFR and ErbB2 tyrosine kinase inhibitor GW572016 sensitizes human colon carcinoma GEO cells to apoptosis. Cancer Research. 66: 404-11. PMID 16397255 DOI: 10.1158/0008-5472.Can-05-2506 |
0.606 |
|
| 2006 |
Rose R, Wang J, Hu P, Le Vea C, Brattain M, Rajput A. Characterization of the GEO human colon cancer cell line in an orthotopic model of colon cancer Journal of Surgical Research. 130: 258. DOI: 10.1016/J.Jss.2005.11.276 |
0.359 |
|
| 2006 |
Rajput A, Wang J, Foster J, Dawson D, Willis J, Brattain M, Willson J. The role of autocrine transforming growth factor alpha in Epidermal Growth Factor receptor mediated tumorigenicity Journal of Surgical Research. 130: 192-193. DOI: 10.1016/J.Jss.2005.11.088 |
0.368 |
|
| 2005 |
Javle MM, Yu J, Chadha M, Khoury T, Levea CM, Gibbs JF, Iyer RV, Oleszek D, Brattain MG, Black JD. MAPK activation predicts poor survival after pancreatico-duodenectomy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 9578. PMID 27944052 DOI: 10.1200/Jco.2005.23.16_Suppl.9578 |
0.346 |
|
| 2005 |
Zhou Y, Brattain MG. Synergy of epidermal growth factor receptor kinase inhibitor AG1478 and ErbB2 kinase inhibitor AG879 in human colon carcinoma cells is associated with induction of apoptosis. Cancer Research. 65: 5848-56. PMID 15994962 DOI: 10.1158/0008-5472.Can-04-3509 |
0.642 |
|
| 2005 |
Hu YP, Venkateswarlu S, Sergina N, Howell G, St Clair P, Humphrey LE, Li W, Hauser J, Zborowska E, Willson JK, Brattain MG. Reorganization of ErbB family and cell survival signaling after Knock-down of ErbB2 in colon cancer cells. The Journal of Biological Chemistry. 280: 27383-92. PMID 15888451 DOI: 10.1074/Jbc.M414238200 |
0.503 |
|
| 2005 |
Huang W, Zhao S, Ammanamanchi S, Brattain M, Venkatasubbarao K, Freeman JW. Trichostatin A induces transforming growth factor beta type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1.NF-Y complex. The Journal of Biological Chemistry. 280: 10047-54. PMID 15647279 DOI: 10.1074/Jbc.M408680200 |
0.402 |
|
| 2005 |
Li F, Ling X, Huang H, Brattain L, Apontes P, Wu J, Binderup L, Brattain MG. Differential regulation of survivin expression and apoptosis by vitamin D3 compounds in two isogenic MCF-7 breast cancer cell sublines. Oncogene. 24: 1385-95. PMID 15608672 DOI: 10.1038/Sj.Onc.1208330 |
0.448 |
|
| 2004 |
Sawhney RS, Cookson MM, Sharma B, Hauser J, Brattain MG. Autocrine transforming growth factor alpha regulates cell adhesion by multiple signaling via specific phosphorylation sites of p70S6 kinase in colon cancer cells. The Journal of Biological Chemistry. 279: 47379-90. PMID 15304500 DOI: 10.1074/Jbc.M402031200 |
0.458 |
|
| 2004 |
Wang J, Sergina N, Ko TC, Gong J, Brattain MG. Autocrine and exogenous transforming growth factor beta control cell cycle inhibition through pathways with different sensitivity. The Journal of Biological Chemistry. 279: 40237-44. PMID 15271980 DOI: 10.1074/Jbc.M401665200 |
0.406 |
|
| 2004 |
Ammanamanchi S, Brattain MG. Restoration of transforming growth factor-beta signaling through receptor RI induction by histone deacetylase activity inhibition in breast cancer cells. The Journal of Biological Chemistry. 279: 32620-5. PMID 15155736 DOI: 10.1074/Jbc.M402691200 |
0.409 |
|
| 2004 |
Wilkinson NW, Black JD, Roukhadze E, Driscoll D, Smiley S, Hoshi H, Geradts J, Javle M, Brattain M. Epidermal growth factor receptor expression correlates with histologic grade in resected esophageal adenocarcinoma. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. 8: 448-53. PMID 15120370 DOI: 10.1016/J.Gassur.2004.01.006 |
0.321 |
|
| 2004 |
Jackson JG, St Clair P, Sliwkowski MX, Brattain MG. Blockade of epidermal growth factor- or heregulin-dependent ErbB2 activation with the anti-ErbB2 monoclonal antibody 2C4 has divergent downstream signaling and growth effects. Cancer Research. 64: 2601-9. PMID 15059917 DOI: 10.1158/0008-5472.Can-03-3106 |
0.437 |
|
| 2004 |
Ammanamanchi S, Tillekeratne MP, Ko TC, Brattain MG. Endogenous control of cell cycle progression by autocrine transforming growth factor beta in breast cancer cells. Cancer Research. 64: 2509-15. PMID 15059906 DOI: 10.1158/0008-5472.Can-03-2654 |
0.429 |
|
| 2004 |
Ling X, Bernacki RJ, Brattain MG, Li F. Induction of survivin expression by taxol (paclitaxel) is an early event, which is independent of taxol-mediated G2/M arrest. The Journal of Biological Chemistry. 279: 15196-203. PMID 14722122 DOI: 10.1074/Jbc.M310947200 |
0.41 |
|
| 2004 |
Rajput A, Harrington R, Mazurchuk R, Humphrey L, Brattain M. Constitutive activation of EGFR results in a highly metastatic phenotype in an orthotopic model of colon cancer Journal of Surgical Research. 121: 308-309. DOI: 10.1016/J.Jss.2004.07.137 |
0.394 |
|
| 2003 |
DeArmond D, Brattain MG, Jessup JM, Kreisberg J, Malik S, Zhao S, Freeman JW. Autocrine-mediated ErbB-2 kinase activation of STAT3 is required for growth factor independence of pancreatic cancer cell lines. Oncogene. 22: 7781-95. PMID 14586404 DOI: 10.1038/Sj.Onc.1206966 |
0.505 |
|
| 2003 |
Awwad RA, Sergina N, Yang H, Ziober B, Willson JK, Zborowska E, Humphrey LE, Fan R, Ko TC, Brattain MG, Howell GM. The role of transforming growth factor alpha in determining growth factor independence. Cancer Research. 63: 4731-8. PMID 12907656 |
0.392 |
|
| 2003 |
Ammanamanchi S, Freeman JW, Brattain MG. Acetylated sp3 is a transcriptional activator. The Journal of Biological Chemistry. 278: 35775-80. PMID 12837748 DOI: 10.1074/Jbc.M305961200 |
0.398 |
|
| 2003 |
Malik SN, Bedolla RG, Hidalgo M, Brattain MG, Kreisberg JI. Immunohistochemical determination of EGFR-tyrosine kinase inhibition in clinical samples. Methods in Molecular Medicine. 85: 135-40. PMID 12710204 DOI: 10.1385/1-59259-380-1:135 |
0.301 |
|
| 2003 |
Sawhney RS, Sharma B, Humphrey LE, Brattain MG. Integrin alpha2 and extracellular signal-regulated kinase are functionally linked in highly malignant autocrine transforming growth factor-alpha-driven colon cancer cells. The Journal of Biological Chemistry. 278: 19861-9. PMID 12657625 DOI: 10.1074/Jbc.M213162200 |
0.423 |
|
| 2003 |
Kim HS, Brattain MG, Fan Z. Co-targeting integrin adhesion receptors and epidermal growth factor receptors as a strategy for cancer therapy Gastroenterology. 124: A285. DOI: 10.1016/S0016-5085(03)81433-6 |
0.339 |
|
| 2002 |
Bandyopadhyay A, Zhu Y, Malik SN, Kreisberg J, Brattain MG, Sprague EA, Luo J, López-Casillas F, Sun LZ. Extracellular domain of TGFbeta type III receptor inhibits angiogenesis and tumor growth in human cancer cells. Oncogene. 21: 3541-51. PMID 12032856 DOI: 10.1038/Sj.Onc.1205439 |
0.447 |
|
| 2002 |
Wang D, Patil S, Li W, Humphrey LE, Brattain MG, Howell GM. Activation of the TGFalpha autocrine loop is downstream of IGF-I receptor activation during mitogenesis in growth factor dependent human colon carcinoma cells. Oncogene. 21: 2785-96. PMID 11973637 DOI: 10.1038/Sj.Onc.1205375 |
0.476 |
|
| 2002 |
Venkateswarlu S, Dawson DM, St Clair P, Gupta A, Willson JK, Brattain MG. Autocrine heregulin generates growth factor independence and blocks apoptosis in colon cancer cells. Oncogene. 21: 78-86. PMID 11791178 DOI: 10.1038/Sj.Onc.1205011 |
0.498 |
|
| 2002 |
Sawhney RS, Zhou GH, Humphrey LE, Ghosh P, Kreisberg JI, Brattain MG. Differences in sensitivity of biological functions mediated by epidermal growth factor receptor activation with respect to endogenous and exogenous ligands. The Journal of Biological Chemistry. 277: 75-86. PMID 11684674 DOI: 10.1074/Jbc.M103268200 |
0.426 |
|
| 2001 |
Venkatasubbarao K, Ammanamanchi S, Brattain MG, Mimari D, Freeman JW. Reversion of transcriptional repression of Sp1 by 5 aza-2′ deoxycytidine restores TGF-β type II receptor expression in the pancreatic cancer cell line MIA PaCa-2 Cancer Research. 61: 6239-6247. PMID 11507078 |
0.315 |
|
| 2001 |
Yang L, Yang J, Venkateswarlu S, Ko T, Brattain MG. Autocrine TGFβ signaling mediates vitamin D3 analog-induced growth inhibition in breast cells Journal of Cellular Physiology. 188: 383-393. PMID 11473365 DOI: 10.1002/Jcp.1125 |
0.412 |
|
| 2001 |
Ammanamanchi S, Brattain MG. 5-AzaC Treatment Enhances Expression of Transforming Growth Factor-β Receptors through Down-regulation of Sp3 Journal of Biological Chemistry. 276: 32854-32859. PMID 11443124 DOI: 10.1074/Jbc.M103951200 |
0.397 |
|
| 2001 |
Ammanamanchi S, Brattain MG. Sp3 Is a Transcriptional Repressor of Transforming Growth Factor-β Receptors Journal of Biological Chemistry. 276: 3348-3352. PMID 11027677 DOI: 10.1074/Jbc.M002462200 |
0.434 |
|
| 2000 |
Periyasamy S, Ammanamanchi S, Tillekeratne MPM, Brattain MG. Repression of transforming growth factor-β receptor type I promoter expression by Sp1 deficiency Oncogene. 19: 4660-4667. PMID 11030155 DOI: 10.1038/Sj.Onc.1203822 |
0.453 |
|
| 2000 |
Jackson JG, Kreisberg JI, Koterba AP, Yee D, Brattain MG. Phosphorylation and nuclear exclusion of the forkhead transcription factor FKHR after epidermal growth factor treatment in human breast cancer cells. Oncogene. 19: 4574-81. PMID 11030146 DOI: 10.1038/Sj.Onc.1203825 |
0.421 |
|
| 2000 |
Yang H, Jiang D, Li W, Liang J, Gentry LE, Brattain MG. Defective cleavage of membrane bound TGFα leads to enhanced activation of the EGF receptor in malignant cells Oncogene. 19: 1901-1914. PMID 10773880 DOI: 10.1038/Sj.Onc.1203513 |
0.48 |
|
| 2000 |
Liu Y, Zhong X, Li W, Brattain MG, Banerji SS. The role of Sp1 in the differential expression of transforming growth factor-beta receptor type II in human breast adenocarcinoma MCF-7 cells. The Journal of Biological Chemistry. 275: 12231-6. PMID 10766860 DOI: 10.1074/Jbc.275.16.12231 |
0.43 |
|
| 1999 |
Awwad R, Humphrey LE, Periyasamy B, Scovell W, Li W, Coleman K, Lynch M, Carboni J, Brattain MG, Howell GM. The EGF/TGFalpha response element within the TGFalpha promoter consists of a multi-complex regulatory element. Oncogene. 18: 5923-35. PMID 10557079 DOI: 10.1038/Sj.Onc.1202982 |
0.436 |
|
| 1999 |
Ye SC, Foster JM, Li W, Liang J, Zborowska E, Venkateswarlu S, Gong J, Brattain MG, Willson JKV. Contextual effects of transforming growth factor β on the tumorigenicity of human colon carcinoma cells Cancer Research. 59: 4725-4731. PMID 10493532 |
0.312 |
|
| 1999 |
Wang D, Sun L, Zborowska E, Willson JKV, Gong J, Verraraghavan J, Brattain MG. Control of type II transforming growth factor-β receptor expression by integrin ligation Journal of Biological Chemistry. 274: 12840-12847. PMID 10212271 DOI: 10.1074/Jbc.274.18.12840 |
0.396 |
|
| 1998 |
Jiang D, Yang H, Willson JKV, Liang J, Humphrey LE, Zborowska E, Wang D, Foster J, Fan R, Brattain MG. Autocrine transforming growth factor provides a growth advantage to malignant cells by facilitating re-entry into the cell cycle from suboptimal growth states Journal of Biological Chemistry. 273: 31471-31479. PMID 9813060 DOI: 10.1074/Jbc.273.47.31471 |
0.464 |
|
| 1998 |
Wang D, Li W, Jiang W, Humphrey LE, Howell GM, Brattain MG. Autocrine TGFα expression in the regulation of initiation of human colon carcinoma growth Journal of Cellular Physiology. 177: 387-395. PMID 9808147 DOI: 10.1002/(Sici)1097-4652(199812)177:3<387::Aid-Jcp2>3.0.Co;2-L |
0.482 |
|
| 1998 |
Ko Y, Banerji SS, Liu Y, Li W, Liang J, Soule HD, Pauley RJ, Willson JK, Zborowska E, Brattain MG. Expression of transforming growth factor-beta receptor type II and tumorigenicity in human breast adenocarcinoma MCF-7 cells. Journal of Cellular Physiology. 176: 424-34. PMID 9648930 DOI: 10.1002/(Sici)1097-4652(199808)176:2<424::Aid-Jcp21>3.0.Co;2-1 |
0.438 |
|
| 1998 |
Ammanamanchi S, Kim SJ, Sun LZ, Brattain MG. Induction of transforming growth factor-β receptor type II expression in estrogen receptor-positive breast cancer cells through SP1 activation by 5-aza-2'-deoxycytidine Journal of Biological Chemistry. 273: 16527-16534. PMID 9632722 DOI: 10.1074/Jbc.273.26.16527 |
0.432 |
|
| 1998 |
Howell GM, Humphrey LE, Awwad RA, Wang D, Koterba A, Periyasamy B, Yang J, Li W, Willson JK, Ziober BL, Coleman K, Carboni J, Lynch M, Brattain MG. Aberrant regulation of transforming growth factor-alpha during the establishment of growth arrest and quiescence of growth factor independent cells. The Journal of Biological Chemistry. 273: 9214-23. PMID 9535913 DOI: 10.1074/Jbc.273.15.9214 |
0.472 |
|
| 1998 |
Jiang D, Liang J, Humphrey LE, Yang H, Brattain MG. Expression of TGFα autocrine activity in human colon carcinoma CBS cells is autoregulated and independent of exogenous epidermal growth factor Journal of Cellular Physiology. 175: 174-183. PMID 9525476 DOI: 10.1002/(SICI)1097-4652(199805)175:2<174::AID-JCP7>3.0.CO;2-L |
0.393 |
|
| 1998 |
Wu G, Fan RS, Li W, Srinivas V, Brattain MG. Regulation of transforming growth factor-β type II receptor expression in human breast cancer MCF-7 cells by vitamin D3 and its analogues Journal of Biological Chemistry. 273: 7749-7756. PMID 9516484 DOI: 10.1074/Jbc.273.13.7749 |
0.493 |
|
| 1998 |
Foster JM, Willis J, Brattain M, Willson JK. TGFα over expression result in in vivo progression of a weakly tumorigenic colon cancer cells Gastroenterology. 114: A596-A597. DOI: 10.1016/S0016-5085(98)82432-3 |
0.399 |
|
| 1997 |
Jiang W, Tillekeratne MP, Brattain MG, Banerji SS. Decreased stability of transforming growth factor beta type II receptor mRNA in RER+ human colon carcinoma cells. Biochemistry. 36: 14786-93. PMID 9402753 DOI: 10.1021/Bi9717892 |
0.42 |
|
| 1997 |
Wu G, Fan RS, Li W, Ko TC, Brattain MG. Modulation of cell cycle control by vitamin D3 and its analogue, EB1089, in human breast cancer cells Oncogene. 15: 1555-1563. PMID 9380407 DOI: 10.1038/Sj.Onc.1201329 |
0.423 |
|
| 1997 |
Koli KM, Ramsey TT, Ko Y, Dugger TC, Brattain MG, Arteaga CL. Blockade of transforming growth factor-β signaling does not abrogate antiestrogen-induced growth inhibition of human breast carcinoma cells Journal of Biological Chemistry. 272: 8296-8302. PMID 9079651 DOI: 10.1074/Jbc.272.13.8296 |
0.345 |
|
| 1996 |
Dobre C, Ziober B, Humphrey L, Brattain M. Autocrine transforming growth factor-alpha is associated with modulation of a 130 kD RB protein species and 116/110 Rb as revealed by an antisense TGF alpha expression vector. International Journal of Oncology. 8: 1025-33. PMID 21544460 DOI: 10.3892/Ijo.8.6.1025 |
0.311 |
|
| 1996 |
Dobre C, Humphrey L, Brattain M. Autocrine transforming growth factor-beta (TGF beta) modulates the 120 kD and 105 kD retinoblastoma (RB) protein species in CBS colon carcinoma cells as revealed by an anti-sense TGF beta 1 expression vector. International Journal of Oncology. 8: 469-75. PMID 21544384 DOI: 10.3892/Ijo.8.3.469 |
0.336 |
|
| 1996 |
Brattain MG, Markowitz SD, Willson JKV. The type II transforming growth factor-β receptor as a tumor-suppressor gene Current Opinion in Oncology. 8: 49-53. PMID 8868100 DOI: 10.1097/00001622-199601000-00009 |
0.411 |
|
| 1996 |
Periyasamy S, Sun L, Gentry LE, Brattain MG. Differential control of expression of type I and type II receptors of transforming growth factor-β in colon carcinoma cells Journal of Cellular Physiology. 168: 711-720. PMID 8816926 DOI: 10.1002/(Sici)1097-4652(199609)168:3<711::Aid-Jcp24>3.0.Co;2-# |
0.455 |
|
| 1996 |
Wang J, Han W, Zborowska E, Liang J, Wang X, Willson JKV, Sun L, Brattain MG. Reduced expression of transforming growth factor β type I receptor contributes to the malignancy of human colon carcinoma cells Journal of Biological Chemistry. 271: 17366-17371. PMID 8663343 DOI: 10.1074/Jbc.271.29.17366 |
0.517 |
|
| 1995 |
Howell GM, Ziober BL, Humphrey LE, Willson JKV, Sun L, Lynch M, Brattain MG. Regulation of autocrine gastrin expression by the TGFα autocrine loop Journal of Cellular Physiology. 162: 256-265. PMID 7822434 DOI: 10.1002/Jcp.1041620211 |
0.464 |
|
| 1995 |
Wang D, Birkenmeier TM, Yang J, Venkateswarlu S, Humphrey L, Brattain MG, Sun L. Release from quiescence stimulates the expression of integrin α5β1 which regulates DNA synthesis in human fibrosarcoma HT1080 cells Journal of Cellular Physiology. 164: 499-508. PMID 7650060 DOI: 10.1002/Jcp.1041640308 |
0.348 |
|
| 1995 |
Zhou GHK, Sechrist GL, Brattain MG, Mulder KM. Clonal heterogeneity of the sensitivity of human colon carcinoma cell lines to TGFβ isoforms Journal of Cellular Physiology. 165: 512-520. PMID 7593230 DOI: 10.1002/Jcp.1041650309 |
0.421 |
|
| 1995 |
Wang D, Zhou GH, Birkenmeier TM, Gong J, Sun L, Brattain MG. Autocrine transforming growth factor β1 modulates the expression of integrin α5β1 in human colon carcinoma FET cells Journal of Biological Chemistry. 270: 14154-14159. PMID 7539800 DOI: 10.1074/Jbc.270.23.14154 |
0.403 |
|
| 1994 |
Brattain MG, Howell G, Sun LuZhe, Willson JKV. Growth factor balance and tumor progression Current Opinion in Oncology. 6: 77-81. PMID 8204695 DOI: 10.1097/00001622-199401000-00011 |
0.318 |
|
| 1994 |
Sun L, Shaoping WU, Coleman K, Fields KC, Humphrey LE, Brattain MG. Autocrine transforming growth factor-β1 and β2 expression is increased by cell crowding and quiescence in colon carcinoma cells Experimental Cell Research. 214: 215-224. PMID 8082724 DOI: 10.1006/Excr.1994.1251 |
0.385 |
|
| 1994 |
Sun L, Wu G, Willson JKV, Zborowska E, Yang J, Rajkarunanayake I, Wang J, Gentry LE, Wang XF, Brattain MG. Expression of transforming growth factor β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells Journal of Biological Chemistry. 269: 26449-26455. PMID 7929366 |
0.371 |
|
| 1993 |
Ziober BL, Willson JKV, Hymphrey LE, Childress-Fields K, Brattain MG. Autocrine transforming growth factor-α is associated with progression of transformed properties in human colon cancer cells Journal of Biological Chemistry. 268: 691-698. PMID 8416972 |
0.364 |
|
| 1993 |
Lynch MJ, Pelosi L, Carboni JM, Merwin J, Coleman K, Wang RC, Lin PF, Henry DL, Brattain MG. Transforming growth factor-beta 1 induces transforming growth factor-alpha promoter activity and transforming growth factor-alpha secretion in the human colon adenocarcinoma cell line FET. Cancer Research. 53: 4041-7. PMID 8358733 |
0.561 |
|
| 1993 |
Howell GM, Sun L, Ziober BL, Wu SP, Brattain MG. The role of growth regulatory aberrations in progression of human colon carcinoma Cancer and Metastasis Reviews. 12: 275-286. PMID 8281613 DOI: 10.1007/Bf00665958 |
0.461 |
|
| 1993 |
Brattain MG, Mulder KM, Wu SP, Howell G, Sun L, Willson JKV, Ziober BL. Altered Expression of Transforming Growth Factor-α and Transforming Growth Factor-β Autocrine Loops in Cancer Cells Advances in Molecular and Cell Biology. 7: 35-59. DOI: 10.1016/S1569-2558(08)60234-9 |
0.318 |
|
| 1992 |
Wu S, Theodorescu D, Kerbel RS, Willson JKV, Mulder KM, Humphrey LE, Brattain MG. TGF-βi is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector Journal of Cell Biology. 116: 187-196. PMID 1730743 DOI: 10.1083/Jcb.116.1.187 |
0.464 |
|
| 1991 |
Saeki T, Cristiano A, Lynch MJ, Brattain M, Kim N, Normanno N, Kenney N, Ciardiello F, Salomon DS. Regulation by estrogen through the 5′-flanking region of the transforming growth factor α gene Molecular Endocrinology. 5: 1955-1963. PMID 1791840 DOI: 10.1210/Mend-5-12-1955 |
0.371 |
|
| 1991 |
Long BH, Wang L, Lorico A, Wang RC, Brattain MG, Casazza AM. Mechanisms of resistance to etoposide and teniposide in acquired resistant human colon and lung carcinoma cell lines. Cancer Research. 51: 5275-83. PMID 1717144 |
0.505 |
|
| 1990 |
Hoosein NM, Kiener PA, Curry RC, Brattain MG. Evidence for autocrine growth stimulation of cultured colon tumor cells by a gastrin/cholecystokinin-like peptide Experimental Cell Research. 186: 15-21. PMID 2298233 DOI: 10.1016/0014-4827(90)90204-N |
0.417 |
|
| 1990 |
Mulder KM, Humphrey LE, Choi HG, Childress-Fields KE, Brattain MG. Evidence for c-myc in the signaling pathway for TGF-β in well-differentiated human colon carcinoma cells Journal of Cellular Physiology. 145: 501-507. PMID 2273056 DOI: 10.1002/Jcp.1041450316 |
0.417 |
|
| 1990 |
Mulder KM, Zhong Q, Choi HG, Humphrey LE, Brattain MG. Inhibitory Effects of Transforming Growth Factor β x on Mitogenic Response, Transforming Growth Factor a, and c-myc in Quiescent, Well-Differentiated Colon Carcinoma Cells Cancer Research. 50: 7581-7586. PMID 1701348 |
0.357 |
|
| 1989 |
Levine AE, Black B, Brattain MG. Effects of N,N-dimethylformamide and extracellular matrix on transforming growth factor-β binding to a human colon carcinoma cell line Journal of Cellular Physiology. 138: 459-466. PMID 2925796 DOI: 10.1002/Jcp.1041380304 |
0.43 |
|
| 1989 |
Mulder KM, Brattain MG. Effects of growth stimulatory factors on mitogenicity and c-myc expression in poorly differentiated and well differentiated human colon carcinoma cells Molecular Endocrinology. 3: 1215-1222. PMID 2674694 DOI: 10.1210/Mend-3-8-1215 |
0.428 |
|
| 1989 |
Mulder KM, Brattain MG. Continous maintenance of transformed fibroblasts under reduced serum conditions: Utility as a model system for investigating growth factor-specific effects in nonquiescent cells Journal of Cellular Physiology. 138: 450-458. PMID 2647770 DOI: 10.1002/Jcp.1041380303 |
0.458 |
|
| 1989 |
Hoosein NM, Black BE, Brattain DE, Brattain MG. Promotion of differentiation in human colon carcinoma cells by vasoactive intestinal polypeptide. Regulatory Peptides. 24: 15-26. PMID 2544928 DOI: 10.1016/0167-0115(89)90207-3 |
0.454 |
|
| 1989 |
Hoosein NM, Thim L, Jørgensen KH, Brattain MG. Growth stimulatory effect of pancreatic spasmolytic polypeptide on cultured colon and breast tumor cells Febs Letters. 247: 303-306. PMID 2541019 DOI: 10.1016/0014-5793(89)81357-2 |
0.437 |
|
| 1989 |
Chakrabarty S, Jan Y, Brattain MG, Tobon A, Varani J. Diverse cellular responses elicited from human colon carcinoma cells by transforming growth factor-beta. Cancer Research. 49: 2112-7. PMID 2539253 |
0.34 |
|
| 1989 |
Hoosein NM, McKnight MK, Levine AE, Mulder KM, Childress KE, Brattain DE, Brattain MG. Differential sensitivity of subclasses of human colon carcinoma cell lines to the growth inhibitory effects of transforming growth factor-β1 Experimental Cell Research. 181: 442-453. PMID 2538337 DOI: 10.1016/0014-4827(89)90101-8 |
0.393 |
|
| 1988 |
McKibbin J, Arcolano L, Karlsson KA, Larson G, Thurin J, Brattain M. Glycosphingolipids of cultured human colon carcinoma cells and their drug-resistant sublines. Biochimica Et Biophysica Acta. 958: 235-46. PMID 3337838 DOI: 10.1016/0005-2760(88)90182-8 |
0.362 |
|
| 1988 |
Chakrabarty S, Tobon A, Varani J, Brattain MG. Induction of carcinoembryonic antigen secretion and modulation of protein secretion/expression and fibronectin/laminin expression in human colon carcinoma cells by transforming growth factor-beta. Cancer Research. 48: 4059-64. PMID 3289738 |
0.305 |
|
| 1988 |
Boyd DD, Levine AE, Brattain DE, McKnight MK, Brattain MG. Comparison of Growth Requirements of Two Human Intratumoral Colon Carcinoma Cell Lines in Monolayer and Soft Agarose Cancer Research. 48: 2469-2474. PMID 3281751 |
0.311 |
|
| 1988 |
Wan CW, McKnight MK, Brattain DE, Brattain MG, Yeoman LC. Different epidermal growth factor growth responses and receptor levels in human colon carcinoma cell lines Cancer Letters. 43: 139-143. PMID 3264518 DOI: 10.1016/0304-3835(88)90226-1 |
0.441 |
|
| 1988 |
Watkins LF, Brattain MG, Levine AE. Modulation of a high molecular weight form of transforming growth factor-α in human colon carcinoma cell lines Cancer Letters. 40: 59-70. PMID 3259465 DOI: 10.1016/0304-3835(88)90262-5 |
0.414 |
|
| 1988 |
Hoosein NM, Kiener PA, Curry RC, Rovati LC, McGilbra DK, Brattain MG. Antiproliferative effects of gastrin receptor antagonists and antibodies to gastrin on human colon carcinoma cell lines Cancer Research. 48: 7179-7183. PMID 3191491 |
0.357 |
|
| 1988 |
Mulder KM, Brattain MG. Alterations in c-myc expression in relation to maturational status of human colon carcinoma cells International Journal of Cancer. 42: 64-70. PMID 3164710 DOI: 10.1002/Ijc.2910420113 |
0.457 |
|
| 1988 |
Boyd D, Florent G, Childress-Fields K, Brattain MG. Alteration in the behavior of a colon carcinoma cell line by extracellular matrix components Cancer Letters. 41: 81-90. PMID 3164644 DOI: 10.1016/0304-3835(88)90058-4 |
0.47 |
|
| 1988 |
Hoosein NM, Brattain DE, McKnight MK, Childress KE, Chakrabarty S, Brattain MG. Comparison of the antiproliferative effects of transforming growth factor-beta, N,N-dimethylformamide and retinoic acid on a human colon carcinoma cell line. Cancer Letters. 40: 219-32. PMID 3164250 DOI: 10.1016/0304-3835(88)90014-6 |
0.423 |
|
| 1988 |
Boyd D, Florent G, Chakrabarty S, Brattain D, Brattain MG. Alterations of the biological characteristics of a colon carcinoma cell line by colon-derived substrata material. Cancer Research. 48: 2825-31. PMID 3162826 |
0.36 |
|
| 1988 |
Hoosein NM, Brattain DE, McKnight MK, Brattain MG. Comparison of the effects of transforming growth factor β, N,N-dimethylformamide, and retinoic acid on transformed and nontransformed fibroblasts Experimental Cell Research. 175: 125-135. PMID 3162213 DOI: 10.1016/0014-4827(88)90260-1 |
0.431 |
|
| 1988 |
Mulder KM, Levine AE, Hernandez X, McKnight MK, Brattain DE, Brattain MG. Modulation of C-myc by transforming growth factor-β in human colon carcinoma cells Biochemical and Biophysical Research Communications. 150: 711-716. PMID 2893611 DOI: 10.1016/0006-291X(88)90449-4 |
0.445 |
|
| 1988 |
Boyd D, Florent G, Murano G, Brattain M. Modulation of the urokinase receptor in human colon cell lines by N,N-dimethylformamide. Biochimica Et Biophysica Acta. 970: 96-100. PMID 2835992 DOI: 10.1016/0167-4889(88)90227-3 |
0.39 |
|
| 1987 |
Boyd D, Bialoski S, Brattain MG. The specific binding of transferrin to the murine fibroblast cell lines AKR-2B and its malignant counterpart AKR-MCA may be related to the transformed state Cancer Letters. 36: 263-271. PMID 3652028 DOI: 10.1016/0304-3835(87)90019-X |
0.325 |
|
| 1987 |
Hoosein NM, Brattain DE, McKnight MK, Levine AE, Brattain MG. Characterization of the Inhibitory Effects of Transforming Growth Factor-β on a Human Colon Carcinoma Cell Line Cancer Research. 47: 2950-2954. PMID 3471320 |
0.386 |
|
| 1987 |
Chakrabarty S, Brattain MG, Ochs RL, Varani J. Modulation of fibronectin, laminin, and cellular adhesion in the transformation and differentiation of murine AKR fibroblasts. Journal of Cellular Physiology. 133: 415-25. PMID 3320063 DOI: 10.1002/Jcp.1041330302 |
0.394 |
|
| 1987 |
Chakrabarty S, Brattain MG. Molecular comparisons of acquired and native mitomycin C resistance in human colon carcinoma cells. Cancer Letters. 37: 267-76. PMID 3119191 DOI: 10.1016/0304-3835(87)90111-X |
0.347 |
|
| 1987 |
Levine AE, Crandall CA, Brattain MG. Regulation of growth inhibitory activity in transformed mouse embryo fibroblasts Experimental Cell Research. 171: 357-366. PMID 2887448 DOI: 10.1016/0014-4827(87)90168-6 |
0.494 |
|
| 1986 |
Chakrabarty S, Miller CA, Brattain MG. Selective modifications of cellular proteins in intratumoral subpopulations of human colonic carcinoma cells. Cancer Investigation. 4: 5-14. PMID 3955419 DOI: 10.3109/07357908609039822 |
0.38 |
|
| 1986 |
Levine AE, Crandall CA, Brattain D, Chakrabarty S, Brattain MG. Retinoic acid restores normal growth control to a transformed mouse embryo fibroblast cell line. Cancer Letters. 33: 33-43. PMID 3490304 DOI: 10.1016/0304-3835(86)90099-6 |
0.434 |
|
| 1986 |
Chakrabarty S, Brattain MG. Transforming growth factors from human colonic carcinoma cells induced molecular alterations in untransformed mouse AKR embryo fibroblasts. Cell Biology International Reports. 10: 891-5. PMID 3466722 DOI: 10.1016/0309-1651(86)90107-4 |
0.464 |
|
| 1985 |
Chakrabarty S, Jan Y, Miller CA, Brattain MG. Selective nuclear protein phosphorylation/dephosphorylation in subpopulations of human colonic carcinoma cells. Cancer Letters. 28: 291-7. PMID 4052998 DOI: 10.1016/0304-3835(85)90037-0 |
0.351 |
|
| 1985 |
Chakrabarty S, Jan Y, Son J, Miller CA, Brattain MG. Selective phosphorylation of cytosol proteins associated with transformation and restoration of normal phenotype in AKR mouse embryo fibroblasts. Cancer Research. 45: 2170-6. PMID 3872713 |
0.328 |
|
| 1985 |
Chakrabarty S, Brattain MG. Modulation of cellular phosphoprotein profiles in transformation and redifferentiation of murine AKR embryonic fibroblastic cells. Cancer Letters. 29: 151-5. PMID 3865700 DOI: 10.1016/0304-3835(85)90153-3 |
0.438 |
|
| 1985 |
Levine AE, McRae LJ, Hamilton DA, Brattain DE, Yeoman LC, Brattain MG. Identification of endogenous inhibitory growth factors from a human colon carcinoma cell line. Cancer Research. 45: 2248-54. PMID 3857117 |
0.395 |
|
| 1985 |
Marks ME, Ziober BL, Brattain MG. Cell surface features associated with differentiation-induction of methylcholanthrene-transformed AKR-2B fibroblasts by N,N-dimethylformamide. Cancer Research. 45: 1276-84. PMID 3855694 |
0.302 |
|
| 1985 |
Levine AE, McRae LJ, Brattain MG. Changes in Receptor Occupancy and Growth Factor Responsiveness Induced by Treatment of a Transformed Mouse Embryo Cell Line with N,N-Dimethylformamide Cancer Research. 45: 6401-6405. PMID 2998599 |
0.365 |
|
| 1985 |
Levine AE, Hamilton DA, McRae LJ, Brattain MG. Elevated growth factor levels in transformed mouse embryo cells treated with N,N-dimethylformamide. Cancer Research. 45: 108-11. PMID 2981156 |
0.322 |
|
| 1984 |
Levine AE, Hamilton DA, Yeoman LC, Busch H, Brattain MG. Identification of a tumor inhibitory factor in rat ascites fluid. Biochemical and Biophysical Research Communications. 119: 76-82. PMID 6704134 DOI: 10.1016/0006-291X(84)91620-6 |
0.427 |
|
| 1984 |
Chakrabarty S, McRae LJ, Levine AE, Brattain MG. Restoration of normal growth control and membrane antigen composition in malignant cells by N,N-dimethylformamide. Cancer Research. 44: 2181-5. PMID 6608991 |
0.338 |
|
| 1984 |
Marks ME, Brattain MG. Induction of plasma membrane alterations in AKR-2B mouse embryo fibroblasts by endogenous growth factors from malignant human cells. International Journal of Cancer. Journal International Du Cancer. 33: 139-46. PMID 6582050 DOI: 10.1002/Ijc.2910330121 |
0.448 |
|
| 1984 |
Brattain MG, Levine AE, Chakrabarty S, Yeoman LC, Willson JK, Long B. Heterogeneity of human colon carcinoma. Cancer Metastasis Reviews. 3: 177-91. PMID 6437669 DOI: 10.1007/Bf00048384 |
0.494 |
|
| 1983 |
Brattain MG, Marks ME, McCombs J, Finely W, Brattain DE. Characterization of human colon carcinoma cell lines isolated from a single primary tumour. British Journal of Cancer. 47: 373-81. PMID 6830688 DOI: 10.1038/Bjc.1983.56 |
0.333 |
|
| 1983 |
Marks ME, Danbury BH, Miller CA, Brattain MG. Cell surface proteins and glycoproteins from biologically different human colon carcinoma cell lines. Journal of the National Cancer Institute. 71: 663-71. PMID 6578361 DOI: 10.1093/Jnci/71.4.663 |
0.361 |
|
| 1982 |
Brattain MG, Brattain DE, Sarrif AM, McRae LJ, Fine WD, Hawkins JG. Enhancement of growth of human colon tumor cell lines by feeder layers of murine fibroblasts Journal of the National Cancer Institute. 69: 767-771. PMID 6956756 DOI: 10.1093/Jnci/69.4.767 |
0.381 |
|
| 1981 |
Kimball PM, Hammonds L, Mckibbin JM, Brattain MG, Glover G, Webb M. In Vitro Effects of Glycosphingolipids on Human Tumor Cell Proliferation Proceedings of the Society For Experimental Biology and Medicine. 166: 107-112. PMID 7465568 DOI: 10.3181/00379727-166-41031 |
0.306 |
|
| Show low-probability matches. |